BamSEC and AlphaSense Join Forces
Learn More

ACORDA THERAP.NEW DL-001

OTC: CDG:MU    
Share price (10/14/24): $0.79    
Market cap (10/14/24): $975 thousand
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 4 pages Description of Common Stock
12/34/56
EX-4.7
from S-8 17 pages Acorda Therapeutics, Inc. 2015 Omnibus Incentive Compensation Plan as Amended June 10, 2022
12/34/56
EX-4.2
from 10-K 3 pages Description of Common Stock
12/34/56
EX-4.1
from 10-K 2 pages Indenture or similar
12/34/56
EX-4.5
from S-3 55 pages Acorda Therapeutics, Inc., as Issuer, and [ ], as Trustee, Subordinated Indenture Dated as of [ , ] Subordinated Debt Securities
12/34/56
EX-4.2
from 10-K 3 pages Description of Common Stock
12/34/56
EX-4.1
from 8-K 164 pages Acorda Therapeutics, Inc., the Guarantors Party Hereto, and Wilmington Trust, National Association, as Trustee and Collateral Agent Indenture Dated as of December 23, 2019 6.00% Convertible Senior Secured Notes Due 2024
12/34/56
EX-4.1
from 8-K 56 pages Acorda Therapeutics, Inc. and Computershare Trust Company, N.A., as Rights Agent Rights Agreement Dated as of August 31, 2017
12/34/56
EX-4.1
from S-8 15 pages Acorda Therapeutics, Inc. 2016 Inducement Plan
12/34/56
EX-4.2
from 8-K 90 pages Acorda Therapeutics, Inc. and Wilmington Trust, National Association, as Trustee First Supplemental Indenture Dated as of June 23, 2014 to Indenture Dated as of June 23, 2014 1.75% Convertible Senior Notes Due 2021
12/34/56
EX-4.1
from 8-K 53 pages Acorda Therapeutics, Inc., Company and Wilmington Trust, National Association, Trustee Indenture Dated as of June 23, 2014 Senior Debt Securities
12/34/56
EX-4.3
from S-3ASR 53 pages Acorda Therapeutics, Inc., Company and Wilmington Trust, National Association, Trustee Indenture Dated as of June [—], 2014 Senior Debt Securities
12/34/56
EX-4.4
from S-3ASR 65 pages Acorda Therapeutics, Inc. % Senior Notes Due 20 Indenture Dated as of , 20 Wilmington Trust Company Trustee
12/34/56
EX-4.4
from S-3ASR 63 pages Acorda Therapeutics, Inc. % Senior Notes Due 20 Indenture Dated as of , 20 Wilmington Trust Company Trustee
12/34/56
EX-4.4
from S-3/A 78 pages Acorda Therapeutics, Inc. % Senior Notes Due 20 Indenture Dated as of , 20 Wilmington Trust Company Trustee
12/34/56
EX-4.4
from S-1/A 11 pages Neither This Warrant Nor the Securities 1ssuable Upon Exercise of This Warrant Have Been Registered Under the Securities Act of 1933, as Amended. No Sale or Disposition May Be Effected Except in Compliance With Rule 144 Under Said Act or Without an Effective Registration Statement Related Thereto or an Opinion of Counsel for the Holder, Satisfactory to the Company, That Such Registration Is Not Required Under the Act or Receipt of a No-Action Letter From the Securities and Exchange Commission
12/34/56
EX-4.3
from S-1/A 9 pages Stock Warrant Agreement to Purchase 40,000 Shares of the Common Stock of Acorda Therapeutics, Inc. Dated Effective as of May 1, 1996
12/34/56
EX-4.4
from S-1/A 11 pages Neither This Warrant Nor the Securities 1ssuable Upon Exercise of This Warrant Have Been Registered Under the Securities Act of 1933, as Amended. No Sale or Disposition May Be Effected Except in Compliance With Rule 144 Under Said Act or Without an Effective Registration Statement Related Thereto or an Opinion of Counsel for the Holder, Satisfactory to the Company, That Such Registration Is Not Required Under the Act or Receipt of a No-Action Letter From the Securities and Exchange Commission
12/34/56
EX-4.2
from S-1 6 pages Second Closing Warrant to Purchase Shares of the Series B Preferred Stock of Acorda Therapeutics, Inc
12/34/56
EX-4.1
from S-1 2 pages Fully Paid and Non-Assessable Shares of the Common Stock, Par Value $.001 Per Share, of Acorda Therapeutics, Inc. [Seal] President and Chief Executive Officer Secretary
12/34/56